Patents Assigned to SYNEX MEDICAL INC.
  • Weak signal detection system and method
    Patent number: 11931137
    Abstract: In variants, a method for signal enhancement includes: sampling a set of measurements of a signal source; and determining a SNR-enhanced signal based on the measurements, which, in variants, can include recursively cross-correlating elements for d iterations S200; and determining a SNR-enhanced signal from the cross-correlation outputs. The method functions to determine a SNR-enhanced signal representative of the signal source. The method can optionally include determining an analyte parameter based on the SNR-enhanced signal.
    Type: Grant
    Filed: April 1, 2022
    Date of Patent: March 19, 2024
    Assignee: Synex Medical Inc.
    Inventors: Benjamin Saul Nashman, Sean Kentaro Sullivan Takahashi, Abenezer Teklemariam
  • Wearable blood analyte measurement device and method for measuring blood analyte concentration
    Patent number: 11793429
    Abstract: A wearable blood analyte measurement device includes a casing defining an appendage—receiving bore and having an interior volume. A plurality of magnets is within interior volume. The magnets produce a magnetic field in the bore. A nuclear magnetic resonance (NMR) transceiver is supported by the casing and positioned to emit radiofrequency (RF) pulses to and receive NMR signals from the bore. An electronics assembly is within the interior volume and in communication with the NMR transceiver. A power source is in the interior volume and powers the NMR transceiver and the electronics assembly.
    Type: Grant
    Filed: November 6, 2018
    Date of Patent: October 24, 2023
    Assignee: Synex Medical Inc.
    Inventors: Benjamin Nashman, Sunrose Billing
  • Weak signal detection system and method
    Patent number: 11317822
    Abstract: In variants, a method for signal enhancement includes: sampling a set of measurements of a signal source; and determining a SNR-enhanced signal based on the measurements, which, in variants, can include recursively cross-correlating elements for d iterations S200; and determining a SNR-enhanced signal from the cross-correlation outputs. The method functions to determine a SNR-enhanced signal representative of the signal source. The method can optionally include determining an analyte parameter based on the SNR-enhanced signal.
    Type: Grant
    Filed: July 29, 2021
    Date of Patent: May 3, 2022
    Assignee: Synex Medical Inc.
    Inventors: Benjamin Saul Nashman, Sean Kentaro Sullivan Takahashi, Abenezer Teklemariam
  • WEARABLE BLOOD ANALYTE MEASUREMENT DEVICE AND METHOD FOR MEASURING BLOOD ANALYTE CONCENTRATION
    Publication number: 20210121108
    Abstract: A wearable blood analyte measurement device includes a casing defining an appendage—receiving bore and having an interior volume. A plurality of magnets is within interior volume. The magnets produce a magnetic field in the bore. A nuclear magnetic resonance (NMR) transceiver is supported by the casing and positioned to emit radiofrequency (RF) pulses to and receive NMR signals from the bore. An electronics assembly is within the interior volume and in communication with the NMR transceiver. A power source is in the interior volume and powers the NMR transceiver and the electronics assembly.
    Type: Application
    Filed: November 6, 2018
    Publication date: April 29, 2021
    Applicant: SYNEX MEDICAL INC.
    Inventors: Benjamin NASHMAN, Sunrose BILLING